Application Sponsors
ANDA 201407 | LANNETT CO INC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 25MG;37.5MG | 0 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
FDA Submissions
N/A; Not Applicable | ORIG | 1 | AP | 2011-12-09 | |
Submissions Property Types
TE Codes
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 201407
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"TRIAMTERENE AND HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE; TRIAMTERENE","strength":"25MG;37.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/09\/2011","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2011-12-09
)
)